CytoDyn Inc.·4

Oct 2, 6:08 PM ET

Pourhassan Nader 4

4 · CytoDyn Inc. · Filed Oct 2, 2020

Insider Transaction Report

Form 4
Period: 2020-09-30
Pourhassan Nader
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2020-09-30+500,0001,574,930 total
  • Award

    Non-qualified Stock Option

    2020-09-30+2,000,0002,000,000 total
    Exercise: $3.12Exp: 2030-06-15Common Stock (2,000,000 underlying)
Footnotes (4)
  • [F1]Represents restricted stock units granted pursuant to the Issuer's Amended & Restated 2012 Equity Incentive Plan.
  • [F2]Not applicable.
  • [F3]The option grant was approved by a committee of the Issuer's Board of Directors on June 15, 2020, subject to stockholder approval of the Issuer's Amended & Restated 2012 Equity Incentive Plan (the "Plan") under which the option was granted. The Issuer's stockholders approved the Plan on September 30, 2020.
  • [F4]The stock option vests annually in three equal installments beginning June 15, 2021.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT